Maitreya Medicare logo

Maitreya Medicare financials and balance sheet

NSE: MAITREYAHealthcare Services

Last close ₹144.55up ₹7.55 (5.51%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹137.00.

52-week range of traded prices to 23 Oct 2026
₹103.10Low, 21 Sep 2026₹292.95High, 13 Nov 2025
Market cap
₹98 Cr
P/E
Lossover the last 12 months
P/B
3.5
Dividend yield
Nonein the last 12 months
ROE
−11.3%
Debt to equity
0.83
Volume, NSE
19,60067.4% delivered

3 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Maitreya Medicare annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹48 Cr, year to Mar 2024A loss in the year to Mar 2026, −₹2.47 Cr

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue45
  2. Depreciation−1.5
  3. Other income+1.0
  4. Finance costs−1.5
  5. Profit before tax−2.5
  6. Tax0.0
  7. Net profit−2.5

What the company owns

  • Plant, investments and other assets₹48 Cr
  • Receivables₹11 Cr
  • Cash and bank₹9 Cr
  • Inventory₹1 Cr
  • Current investments₹0 Cr

What pays for it: net worth and liabilities

  • Net worth₹30 Cr
  • Borrowings₹23 Cr
  • Other liabilities₹12 Cr
  • Owed to suppliers₹4 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Maitreya Medicare half-yearly results

₹ croreMar 2024Mar 2025Filed 30 MayMar 2026Filed 29 May
Revenue from operations47.646.744.8
41.841.8–
Materials and goods bought9.38.89.6
Employee costs5.16.3–
Other expenses27.426.7–
Operating profit before depreciation5.84.9–
Operating margin12.2%10.4%–
Materials, % of revenue19.6%18.8%–
Employee costs, % of revenue10.7%13.5%–
Other expenses, % of revenue57.6%57.2%–
Depreciation and amortisation1.31.41.5
Operating profit after depreciation4.53.4–
Other income0.30.61.0
Finance costs0.80.81.5
Profit before one-off items and tax3.93.2−2.4
One-off items0.0––
Profit before tax4.03.2−2.5
1.21.30.0
Net profit2.81.9−2.5
Net margin5.8%4.0%−5.5%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2026: revenue, other income and exceptional items less the total expenses stated do not come to the profit before tax the same statement states, so the operating expenses cannot be told apart from the rest.

Balance sheet

Consolidated, ₹ crore, at 31 March. The last column is the half year to Sep 2026, after the latest full year: the balance sheet at its end.

₹ croreMar 2025Filed 30 MayMar 2026Filed 29 MaySep 2026Half yearFiled 22 Oct
32.929.828.7
32.129.028.0
Share capital12.111.611.5
Reserves19.917.516.5
Belonging to outside owners of subsidiaries0.80.70.7
5.223.123.9
10.815.916.2
4.322.723.6
Total assets48.068.468.4
20.245.146.5
27.823.421.9
Net debt−2.714.416.7
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only. No balance sheet is on record for the year to Mar 2024, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March. The last column is the half year to Sep 2026, after the latest full year: the cash flow over its six months.

₹ croreMar 2025Filed 30 MayMar 2026Filed 29 MaySep 2026Half year
5.18.41.0
6.79.11.8
1.18.50.0
Receivables−1.84.4−0.8
Inventories0.0−0.3−0.6
Payables0.7−0.11.1
Other working capital2.34.50.2
Tax paid−1.5−0.10.0
Capital spending0.00.01.2
Free cash flow5.18.4−0.2
−7.4−26.7−1.4
3.719.0−1.1
Dividends paid0.00.00.0
Shares issued5.20.40.0
Net change in cash1.40.8−1.5
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the year to Mar 2024.

Per share

Consolidated, ₹ per share, years to March.

₹ per shareMar 2024Mar 2025Filed 30 MayMar 2026Filed 29 May
Earnings per share––−₹3.64
Book value per share–₹47.35₹42.84
Shareholder yield–−2.5%−0.3%
Market cap at the year end (₹ crore)81207121
Earnings per share is left blank for the year to Mar 2025: the earnings per share is stated as 0 while the period's profit or loss comes to at least half a paisa a share, so the 0 stands in for a figure the filing does not give.

Ratios

Consolidated, years to March.Maitreya Medicare PE ratio and valuation

RatioMar 2024Mar 2025Filed 30 MayMar 2026Filed 29 May
Revenue growth–−1.9%−3.9%
Operating profit growth–−15.9%–
Net profit growth–−32.1%–
–5.8%−8.1%
––−13.9 pts
From the net margin––−13.8 pts
From asset turnover––1.7 pts
From borrowing––−1.7 pts
Return on capital employed–9.0%–
Cash conversion–270.1%–
Interest cover5.44.3–
Debt to equity–0.160.78
Receivable days–11790
Inventory days–2532
Payable days–134153
Cash conversion cycle, days–8−31
Working capital days–83−1
Asset turnover–0.970.77
Assets per rupee of net worth–1.501.91
Sales per rupee of plant–3.061.10
Capital spending to depreciation–0.000.00
No balance sheet is on record for the year to Mar 2024, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
−4.2%
Measure3 years
Return on equity, average−1.1%
Operating margin, average11.3%
Net margin, average1.4%
Asset turnover, average0.87
Cash conversion cycle, days, average−12
Interest cover, average4.8
Debt to equity, average0.47

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations8.4
Cash from investing−26.7
Cash from financing19.0
Capital spending0.0
Dividends paid0.0
Shares issued for cash0.4
Borrowings raised1.3
Borrowings repaid19.7

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2024Mar 2025Mar 2026
Receivables growth less revenue growthOur threshold 0 percentage points––−22.43
Inventory growth less cost-of-goods growthOur threshold 0 percentage points––33.26
Other current assets growth less revenue growthOur threshold 5 per cent of revenue––−3.46
Effective tax ratePublished threshold 17.16 per cent30.5641.68–
Tax charged less tax paid, % of profitOur threshold 10 percentage points–−4.10–
A threshold marked as ours has no published figure; it is the line we read the check against.